APUS

Apimeds Pharmaceuticals US Inc

Jun 22 • 02:26PM ET

0.9505

-0.1395 -12.80 %

Healthcare • Drug Manufacturers - Specialty & Generic • USA • Nano • AMEX

Today, 2:02 PMNo clear catalyst identified for Apimeds Pharmaceuticals (APUS) 22.78% surge

Peers: AYTU CPHI RMTI TXMD BGM SCYX CPIX CTOR DERM SCLX

Index	-	P/E	-	EPS (ttm)	-2.71	Insider Own	62.68%	Shs Outstand	12.58M	Perf Week	-25.74%
Market Cap	14.34M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	5.63M	Perf Month	-31.62%
Enterprise Value	13.46M	PEG	-	EPS next Q	-	Inst Own	2.97%	Short Float	2.96%	Perf Quarter	-53.86%
Income	-40.66M	P/S	-	EPS this Y	-	Inst Trans	-	Short Ratio	0.78	Perf Half Y	-95.15%
Sales	0.00M	P/B	0.09	EPS next Y	-	ROA	-57.48%	Short Interest	0.17M	Perf YTD	-94.20%
Book/sh	10.05	P/C	1.37	EPS next 5Y	-	ROE	-65.18%	52W High	40.31 -97.64%	Perf Year	-94.17%
Cash/sh	0.69	P/FCF	-	EPS past 3/5Y	-108.43% -	ROIC	-32.11%	52W Low	1.08 -11.58%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	18.59% 14.49%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-1843.39%	Oper. Margin	-	ATR (14)	0.33	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.90	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	31.00	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	0.90	EPS Q/Q	-4340.08%	SMA20	-27.58%	Beta	4.39	Target Price	-
Payout	-	Debt/Eq	0.08	Sales Q/Q	-	SMA50	-67.31%	Rel Volume	1.00	Prev Close	1.09
Employees	7	LT Debt/Eq	0.00	Earnings	-	SMA200	-93.61%	Avg Volume	213.27K	Price	0.95
IPO	May 09, 2025	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	164,464	Change	-12.80%

Apimeds Pharmaceuticals US, Inc. is a clinical stage biopharmaceutical company that engages in the development of Apitox, an intradermally administered bee venom-based toxin. It primarily focuses on developing innovative therapies for inflammation and pain management in knee osteoarthritis (OA) and, to a lesser extent, multiple sclerosis (MS). The company was founded on May 11, 2020 and is headquartered in Matawan, NJ.

PresidentMr. Erik C. Emerson

Chief Financial OfficerMr. Erick J. Frim

Founder & Co-CEODr. Vinod Menon

Co-Chief Executive OfficerMr. Sungjoon Chae

Chief Operating OfficerCaptain Sandeep Singh Yadav

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

APUS

Apimeds Pharmaceuticals US Inc

Upgrade your Finviz experience